- B2C
- Public StagePublicly traded company
Revance Therapeutics Funding
$113.6M
44 rounds
Funding Rounds
U
$10,000,000U
$33,000,000D
$45,000,000D
$25,600,000Investors of Revance Therapeutics
Medicis Pharmaceutical
Pac-Link
Bio*One Capital
Shepherd Ventures
Technology Partners
Education space providing innovative and tested solutions in Kenya
LLC
Custom Living
Vivo Capital
CNF Investments
Rounds
D
Palo Alto Investors
Rounds
D